Figure 5.
Comparison of Kaplan–Meier curves for OS according to the CTC count and PSA level of the mCRPC patients. (a) The patient shows <5 CTCs and a ≥5 CTC difference in OS (56 months versus 21.5 months (HR 4.6, 95% CI, 1.2–17)). (b) The patient shows a PSA level <53 ng/mL and a ≥53 ng/mL difference in OS (56 months versus 16 months (HR 4.4, 95% CI, 0.9–21)).